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Glomerular IgA deposition in pulmonary diseases
Yuzo ENDO and MITSURU HAi
Departments of Immunology and Pathology, Toranomon Hospital, Tokyo, Japan
Glomerular IgA deposition in pulmonary diseases. Glomerular changes
of 70 cases of pulmonary diseases and 25 control cases among 1100
consecutive autopsy cases were studied by light, immunofluorescence,
and electron microscopy. These pulmonary diseases consisted of 11
cases of chronic obstructive bronchiolitis (COB), 15 cases of
bronchopneumonia, 4 cases of acute interstitial pneumonia, 22 cases of
idiopathic interstitial pneumonia (lIP), and 18 cases of lung cancer free
from lIP. Bacteriological examination of the lung was performed in
these cases including control cases on autopsy. Mesangial IgA deposi-
tion was predominant in 25 out of the 70 study cases (36%) frequently
accompanied by C3, whereas slight mesangial IgA deposition was
observed in one of the control cases. Incidence of IgA deposition was
64% in lIP, 54.5% in COB, 13.3% in bronchopneumonia, 16.7% in lung
cancer and 25% in acute interstitial pneumonia. The results of the
present study suggest that recurrence or persistence of inflammatory
processes of the lung leads to IgA-mediated immune abnormalities and
to mild mesangial changes with predominant IgA deposition, which are
similar to the immunopathologic features of IgA nephropathy.
In IgA nephropathy, upper respiratory tract infections are
frequently accompanied by recurrent hematuria [1]. Upper
respiratory tract infections are thought to play an important role
in the pathogenesis of IgA nephropathy. Mucous membranes of
the upper respiratory tract may act as defense mechanisms
against foreign substances present in inhaled air. However, not
only upper respiratory tract, but also the lung or lower respira-
tory tract is a mucosal site protected by IgA as well as 1gM and
cellular immunity [2—4]. These mucous membranes are exposed
to a number of microorganisms and/or other antigenic sub-
stances, which are blocked by cooperation between physical
nonspecific defense mechanisms such as ciliary movement and
acquired specific immune defense mechanisms [5]. Therefore, it
may be possible that lower respiratory tract infections as well
are closely related to the pathogenesis of 'IgA nephropathy.
However, little attention has been given to this possibility in the
literature. The present study is undertaken to investigate these
glomerular changes in pulmonary diseases.
Methods
Ninety-five autopsy cases (male, 67; female, 28) of pulmo-
nary inflammatory diseases, lung cancer, and control cases
were obtained out of 1100 consecutive autopsy cases examined
at the Department of Pathology, Toranomon Hospital in Tokyo,
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Japan, between May 1979 and December 1984. Almost all the
cases studied were examined within 4 hr after death. Seventy
out of the 95 cases were classified into six groups according to
the following pulmonary changes: 11 cases of chronic obstruc-
tive diseases of small airways [6] or chronic obstructive
bronchiolitis which corresponds to a disease commonly called
diffuse panbronchiolitis in Japan [7], 15 cases of bronchopneu-
monia related closely to the direct cause of death, 4 cases of
acute interstitial pneumonia caused by Bleomycin or
pneumocystis carinii, 13 cases of idiopathic interstitial pneumo-
nia (lIP) without lung cancer, 9 cases of lIP associated with lung
cancer, and 18 cases of lung cancer free from lIP. The reason
why the cases of lIP were subdivided into two groups pertaining
to the presence or absence of lung cancer was to study the
influence of lung cancer on glomerular changes. Twenty-five
control cases consisted of myocardial infarction, subarach-
noidal hemorrhage, acute heart failure due to hypokalemia, and
others without fatal pulmonary changes. None of the cases
studied had any evidence to suggest such diseases as systemic
lupus erythematosus, rheumatoid arthritis, overt diabetes
mellitus, malignant hypertension, generalized amyloidosis,
pneumoconiosis, hepatitis B virus antigenemia, chronic hepati-
tis, and liver cirrhosis.
Light microscopy
Kidney tissue samples were fixed in 10% formalin, embedded
in paraffin, cut at 1 to 2 and stained with hematoxylin and
eosin (H & E), periodic acid-Schiff (PAS), Mallory's Azan,
Weigert's elastica-van Gieson, and periodic acid methenamine
silver stain with H & E counterstain (PAM).
Immunofluorescence microscopy
Kidney tissue samples were snapfrozen in dry ice and ace-
tone mixture and stored in a Levco deep freezer at —70°C until
use. Frozen sections were cut at 3 to 4 by a Damon/IEC
cryostat at —20°C. After fixation in acetone, the sections were
incubated with fluorescein isothiocyanate (FITC) conjugated
rabbit antiserum to human IgG, IgA, 1gM, Clq, C3, C4, or
secretory component (SC) (Fuji Zoki, Japan), respectively, in a
moist chamber at 37°C for 30 mm. F/P ratio of each antiserum
used was between 2 and 3. Monospecificity of each antiserum
was checked by Ouchterlony double immunodiffusion method.
The sections were examined under a magnification x 200 with a
fluorescence microscope (Olympus, Japan) equipped with opti-
mal excitation and barrier filter for FITC. The degree of
fluorescence was graded as — (negative), (mild), 1 + (moder-
ate), and 2+ (marked).
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Table 1. Glomerular immunoglobulin, complement, secretory component (SC), and electron dense deposits (EDD) in the 70 study and
25 control cases
Pulmonary changes
Number
of cases
IgG
L M L
IgA
M L
1gM
M L
Clq
M
C3
L M
C4
L M L
SC
M
EDD
L M
Chronic obstructive
bronchiolitis 11 P° 2 6b 3 1 1 5a — 2 —— — 1 5
Bronchopneumoma 15 — — — 2 — 2 I — — 0 2
Acute interstitial
pneumonia 4 — — — 1 — 1 0 1
lIP 13 — 1 — gb 5b — 1 — 7b — — 0 7
liP with lung cancer 9 — 6l 4b 4 — 1 — — 0 5
Lung cancer 18 — — — 3 — 3 — 2 — 3 — 1 — — 0 2
Control 25 — — — I 1 — 1 — — 0 0
Total 95
fine granular immunoiluorescence along glomerular capillary loop; HP,Abbreviations: L, glomerular capillary loop; M, mesangium; m,
idiopathic interstitial pneumonia.
Statistically significant compared with control cases in test:
ap <0.05.
p< 0.01.
Fig. 1. Glomerular changes of a 63-year-old female with chronic
obstructive bronchiolitis. Histological changes are confined to the
mesangium with a mild increase in the matrix. Hypercellularity in the
mesangium is minimal. The capillary wall of the glomerulus is normal.
(Periodic acid-Schiff staining; x250)
Electron microscopy
Kidney tissue samples were fixed in 2.5% glutaraldehyde,
buffered with 0.1 M phosphate (pH 7.2), and postflxed in 1%
osmium tetroxide. After being embedded in epoxy resin (Epon
812), sections were cut by a ultramicrotome (Porter-Blum).
Ultrathin sections were stained with uranyl acetate and lead
citrate, and examined with an electron microscope (Hitachi
HU-12).
Bacteriological examination
Five milliliters of blood were obtained on autopsy from the
right and left atrium by a sterile syringe and injected into the
blood culture broth (Eiken, Japan). Four spots of the pleural
Fig. 2. A glomerulus of the same case as in Figure 1, stained with
FITC-labeled rabbit antiserum to human IgA. IgA is diffusely present in
the mesangium. (x200)
surface of bilateral lungs were sterilized by a heated spatula,
and cut by a sterile knife to insert a calibrated inoculating loop
into the lung. Liquid samples taken by this loop were streaked
on culture media, which were incubated at 37°C for more than
a week. The number of bacteria was evaluated by semiquantita-
tive analysis of bacterial colony formation as follows: negative,
1+, 2+, and 3 + in accordance with occupying areas of colonies
on the culture medium. Culture media used were blood agar
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Table 2. Data of the 11 cases of chronic obstructive bronchiolitisa
Serum
Mild IgG IgA 1gM Clq C3 C4 EDD
Case Age Sex IgG IgA 1gM proteinuna L M L M L M L M L M L M L M
1 63 F 2600 1048 188 + — — ++ — — — — ++ — — — +
2 63 F 2820 648 134 + — — — + + — — — —
3 57 F 2320 784 172 + + — — — + + + — — + ÷
4 48 M 2360 708 120 — — — — — — — — +
5 60 F ND ND ND — — — + — — — — + — — +
6 46 F ND ND ND - - - - ± - ± - - - ± - ± - +
7 60 F ND ND ND - - - - - - -
8 57 F 1380 256 158 — — — — — — —
9 68 M 1571 349 100 — — — — — — —
10 69 F 840 507 83 — — — — — — —
11 76 M ND ND ND - - - - - - -
Abbreviations: L, glomerular capillary loop; M, mesangium; m, fine granular immunofluorescence along glomerular capillary loop; ND, not
determined.
a Normal ranges of Immunoglobulins: IgG, 820 to 2290 mg/dl; IgA, 130 to 380 mg/dl; 1gM, 60 to 380 mg/dl.
Table 3. Data of the 22 cases of idiopathic interstitial pneumonia with and without lung cancera
Case Age Sex
Lung
cancer
Serum
IgG IgA 1gM
Mild
proteinuri&'
IgG IgA 1gM Clq C3 C4 EDD
L M L M L M L M L M L M L M
1 71 M — 2560518 172 + — + — ÷ — — — + — ± — — — +
2 59 M — 1880 532 138 + — — — ÷ ± — — — +
3 71 M — 1846 693 127 — — — — + + — — — +
4 58 M — 1995 630 171 — — — — ± ± — — — +
5 85 M - ND ND ND - - - - ± ± - - - +
6 67 M — 3097 423 197 — — — — ± — ± — — — + — — — +
7 67 M — 2760388 132 — — — — ±
8 66 M - ND ND ND - - - - ±
9 71 M — 2760 910 239 — ± — — — ± — — — +
10 51 F — 2800504264 — ±
11 77 F — 1677 225 224 — ±
12 75 M — 1134 433 102 — ±
13 62 M — 1336 398 67 —
14 63 M + 1760 292 246 + — — — ± ± — — — +
15 85 M + ND ND ND + - - - + - ± +
16 48 M + ND ND ND - - - - ± ± - - — +
17 62 M + 1533300 134 — — — — + — ± — — — ± — — — +
18 62 M + 1582 328 219 — — — — ± — ± — — — ± — ± — +
19 64 M + ND ND ND - - - - +
20 65 M + ND ND ND - ±
21 61 M + 1280 192 77 —
22 70 M + ND ND ND -
Abbreviations: L, glomerular capillary loop; M, mesangium; ND, not determined.
a Normal ranges of immunoglobulins: IgG, 820 to 2290 mg/dl; IgA, 130 to 380 mg/dl; 1gM, 60 to 380 mg/dl.l Mild proteinuria was less than 1.0 g/day.
medium (BBL, USA), chocolate agar medium (BBL, USA), Results
modified Drigaiski agar medium (Eiken, Japan) and SabouraudLight microscopy agar with chioromycetin (Eiken, Japan).
Glomeruli of the 70 study cases were almost normal or
showed a mild increase in mesangial matrix with or without
Clinical observations mild hypercellularity (Fig. 1). These mild mesangial changes
were observed in 4 cases consisting of 2 out of the 11 cases of
Age, sex, respiratory function test, radiological examination, chronic obstructive bronchiolitis, one of the 22 cases of TIP with
urinalysis, blood laboratory data, bacteriological data of spu- or without lung cancer, and one of the 18 cases of lung cancer
tum and blood, serum immunoglobulin quantification (Laser free from lIP. Focal or segmental changes of glomeruli were
Nephelometry, Hoechst), rheumatoid factor, antinuclear anti- hardly observed. Double contour of the tuft capillary wall was
body, Coombs and cold hemagglutinin test were recorded from also rare. Membranous glomerulonephntis with spike formation
the clinical files of Toranomon Hospital. was observed in one case of chronic obstructive bronchiolitis.
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C3 showed any significant difference between lIP with and
without lung cancer concerning the incidence of deposition in
the glomeruli. The incidence of C3 in the cases of lIP with or
without lung cancer was statistically significant compared with
that of the control cases (x2 test, P < 0.05 or < 0.01). A
secretory component was not detected in all the cases studied.
Electron microscopy
Ultrastructural examination was performed in the cases pos-
itive for immunofluorescence microscopy. As shown in Tables
1, 2, and 3 electron dense deposits were observed in 5 cases of
chronic obstructive bronchiolitis, 12 cases of lIP with or
without lung cancer, 2 cases of bronchopneumonia, and 2 cases
of lung cancer. Although the deposits tended to be small in size,
one case of chronic obstructive bronchiolitis showed large
electron dense deposits in the mesangium as shown in Figure 4.
Each case of chronic obstructive bronchiolitis and lIP without
lung cancer showed subepithelial fine deposits scattered along
the glomerular basement membrane associated with electron
dense deposits in the mesangium.
Bacteriological examinations (Table 4)
Fig. 3. A glomerulus of the same case as in Figure 1, stained with
FITC-labeled rabbit antiSerum to human C3. Deposition pattern of C3
is similar to that of lgA. (x200)
There was no crescent formation in the glomeruli of the cases
studied.
Immunofluorescence microscopy
IgA deposition was predominant in 25 out of the 70 study
cases (36%), whereas slight IgA deposition was observed in one
of the control cases (Table 1). The pattern of IgA deposition in
the glomeruli was predominantly mesangial (Fig. 2). As shown
in Tables 1, 2, and 3 the incidence of IgA deposition was 54.5%
(6/11) in chronic obstructive bronchiolitis, 61.5% (8/13) in lIP
without lung cancer, 66.7% (6/9) in lIP associated with lung
cancer, respectively. Each incidence of them was statistically
significant compared with that of the control cases (x2test, P <
0.001). On the other hand, the incidence of the IgA deposition
was 13.3% (2/15) in bronchopneumonia, 25% (1/4) in acute
interstitial pneumonia and 16.7% (3/18) in lung cancer free from
lIP. The degree of fluorescence intensity of IgA in the glomeruli
was rather weak as compared with that of typical IgA nephrop-
athy. However, fluorescence intensity of IgA was strong
enough in nine cases studied to be diagnosed as IgA nephrop-
athy and four cases of them histologically showed mild mesan-
gial widening. IgA was frequently accompanied by 1gM, but
less frequently accompanied by IgG in the cases of lIP (Table
3). One of the cases of chronic obstructive bronchiolitis showed
fine granular deposition of IgO along the glomerular capillary
walls associated with IgA and 1gM deposition scattered
sparsely in the mesangium. The deposition pattern of comple-
ment components in the glomeruli was predominantly mesan-
gial (Fig. 3), except for the one case of membranous glomeru-
lonephritis, which showed granular deposition of C3 associated
with IgG along the tuft capillary wall. As shown in Tables 2 and
3, the incidence of C3 deposition was 45.4% (5/11) in chronic
obstructive bronchiolitis, 53.8% (7/13) in lIP and 44.4% (4/9) in
liP associated with lung cancer. Accordingly, neither IgA nor
In the cases of chronic obstructive bronchiolitis, Pseudomo-
nas aeruginosa and its mucoid type were detected in 63.6%
(7/11), whereas in the cases of bronchopneumonia and lung
cancer, various species such as Staphylococcus aureus, Strep-
tococcus faecalis, Escherichia coli, Enterobacter, Candida
albicans, and so forth, were commonly positive in addition to
Pseudomonas aeruginosa. In the cases of lIP, the incidence of
positive bacterial culture was rather less than that detected in
chronic obstructive bronchiolitis: bacteria species detected
were Pseudomonas aeruginosa, Streptococcus faecalis, Kieb-
siella pneumoniae, Enterobacter, Nocardia species, and so
forth. Pseudomonas infection was frequently coincident with
glomerular IgA deposition in the cases of chronic obstructive
bronchiolitis, whereas this tendency was not seen in the cases
of lIP or other pulmonary diseases positive for glomerular IgA
deposition.
Clinical observations
The age of the study cases ranged from 38 to 85 years and that
of the control cases was almost the same (29 to 84 years of age).
The age of the 25 cases positive for glomerular IgA deposition
ranged from 48 to 85 years of age (male, 21; female 4). Chronic
alcoholism was not represented. As shown in Tables 2 and 3,
mild proteinuria (less than 1.0 g/day) was observed in 3 cases of
chronic obstructive bronchiolitis, 2 cases of TIP without lung
cancer, and 2 cases of lung cancer free from lIP. There was no
case associated with hematuria. Serum IgA tended to be higher
than 500 mg/dl in chronic obstructive bronchiolitis and lIP with
or without lung cancer. Initial symptoms of chronic obstructive
bronchiolitis were dyspnea on exertion, cough, and sputum.
Chest x-ray films showed fine nodular shadows diffusely dis-
tributed in the hyperinflated lungs. Sputum culture yielded
Hemophilus influenzae, Streptococcus pneumoniae, or Kiebsi-
ella pneumoniae and most frequently Pseudomonas aeruginosa
at the terminal stage. The time of suffering from this disease in
the cases studied was longer than 7 years. Severe dyspnea was
treated by long-term administration of corticosteroid and anti-
biotics. Initial symptoms of TIP were usually dyspnea on
exertion and cough. In almost all the TIP cases, chest x-ray films
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Fig. 4. Electron micrograph of the glomerular changes of the same case as in Figure 1. Electron dense deposits are present in the mesangium.
(x7,200)
showed elevation of the diaphragm and reticulonodular or small
ring-like shadows on the lower lung field at the first consultation
in Toranomon Hospital. Acute exacerbation of lIP was often
recurrent and treated by corticosteroid and antibiotics. The
disease duration ranged from 2 to 8 years.
Discussion
Because IgA nephropathy is frequently preceded by upper
respiratory tract infections, mucosa of the upper respiratory
tract including tonsils may be an important site of antigenic
entry which presumably leads to IgA nephropathy. Recently,
viral etiology in IgA nephropathy is postulated by Tomino et al
[8] on the basis of of cross-reactivity of IgA antibodies between
renal mesangial areas and nuclei of tonsilar cells. The present
study, however, revealed that chronic inflammatory processes
of the lung such as chronic obstructive bronchiolitis and lIP are
closely related to the predominant IgA deposition in the mesan-
gium associated with deposition of C3, which is similar to the
immunopathologic features of IgA nephropathy originally de-
scribed by Berger [1]. In addition, lung cancer has been shown
not to be concerned in the glomerular IgA deposition. Under
normal conditions, the lung or lower respiratory tract is a
mucosal site protected by IgA as well as 1gM and cellular
immunity [2, 4] which prevent entry of antigens into the
systemic circulation more effectively than the physical integrity
of mucous membrane, mucous layer [9], and ciliary movement.
In general, acute infection of the lung is often caused by
bacteria and easily cured by antibiotics. However, in chronic
obstructive bronchiolitis and lIP, infection and inflammation
were persistent or recurrent and bacterial flora varied in accord-
ance with antibiotics administered. It is noticeable that the
incidence of Pseudomonas infection was prevalent in the cases
of chronic obstructive bronchiolitis in the present study. This
microorganism was substituted for other bacteria or persisted
despite intensive chemotherapies in the long course of the
disease. In lIP, however, bacteria detected on autopsy were not
always Pseudomonas aeruginosa but of various species even in
the terminal stage under treatment of antibiotics and/or corti-
costeroid. Nonetheless, the incidence of glomerular IgA depo-
sition in chronic obstructive bronchiolitis and lIP was so high
that infections of various microorganisms including Pseudo-
monas aeruginosa in the lower respiratory tract may play an
important role in the pathogenesis of glomerular IgA deposi-
tion. As IgA antibodies binding specifically to peptidoglycan of
various bacterial cell wall can be detected in human sera [10,
11], it is likely that recurrent infections of various bacteria in the
lung stimulate IgA-mediated immune mechanisms. IgA in res-
piratory secretions blocks antigen uptake on mucous mem-
branes effectively [12] and appears to form complexes with
antigens [13] or to activate antibody (IgA)-dependent monocyte
or lymphocyte-mediated killing of bacteria [12, 14]. Chronic
inflammation in the lung may alter mucosal permeability and
enhance uptake of immunologically unrelated macromolecules
[15, 16]. The results of the present study suggest that recurrence
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Table 4. Bacterial species identified from the lungs on autopsy
(study cases, 70; control cases, 25)
COB
Broncho-
pneu-
monia
Acute
interstitial
pneumonia lIP
Lung
can-
cer
Con-
trol
Numberofcases 11 15 4 22 18 25
Staphylococcus
aureus 2 1 1
Streptococcus
epidemicus 1 1
a-Streptococcus 1 1 2 1 2
Streptococcus
faecalis 1 2 2
Escherichia coli 2 1
Kiebsiella
pneumoniae 4 1 1
Enterococcus 4 1
Enterobacter 4 1 2
Serratia 1 2 1
Citrobacter 2 2
Proteus 2
Hemophilus
influenzae 1
Pseudomonas
aeruginosa 7 2 1 5 3
Pseudomonas
aeruginosa
(Mucoid) 5
Pseudomonas
cepacia 1
Acinetobacter 1 2
Nocardia species 2
Candida albicans 3 1 3 1
Others 4 6 3
Gram (+) rods
Micrococcus
etc.
Abbreviations: COB, chronic obstructive bronchiolitis; lIP,
pathic interstitial pneumonia with and without lung cancer.
idio-
or persistence of inflammatory processes of the lung leads to
IgA-mediated immune abnormalities and to mild mesangial
changes with predominant IgA deposition, which are similar to
the immunopathologic features of IgA nephropathy.
Reprint requests to Dr. I'. Endo, Department of Immunology,
Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, 105 Tokyo, Japan
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